Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer

BJU International

Volumn 96, Issue 1, 2005, Pages 29-33

  Tewari, Ashutosh ^a   Horninger, Wolfgang ^f   Badani, Ketan K ^a   Hasan, Mazen ^a   Coon, Steven ^a   Crawford, E David ^b,c   Gamito, Eduard J ^b,c   Wei, John ^d   Taub, David ^d   Montie, James ^d   Porter, Chris ^e   Divine, George W ^a   Bartsch, Georg ^f   Menon, Mani ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b Institute for Clinical Research   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e Virginia Mason MS Center   (United States)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

African American; Pathological stage; Prostate cancer; PSA doubling time; PSA recurrence; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; EUROPEAN AMERICAN; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RISK FACTOR; UNITED STATES;

AFRICAN AMERICANS; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 21744457130     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05561.x     Document Type: Article

References (18)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 (Suppl. 8): S4
2. Jemal A, Murray T, Samuels A et al. Cancer statistics 2003. CA Cancer J Clin 2003; 53: 5-26
3. Powell IJ. Prostate cancer in the African American: is this a different disease? Sermin Urol Oncol 1998; 16: 221-6
4. Optenberg SA, Thompson IM, Friedrichs P et al. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA 1995; 274: 1599-605
5. Banerjee M, Powell IJ, George J et al. Prostate specific antigen progression after radical prostatectomy in African-American men versus white men. Cancer 2002; 94: 2577-83
6. Freedland SJ, Jalkut M, Dorey F et al. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology 2000; 56: 87-91
7. Grossfeld GD, Latini DM, Downs T et al. Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy? J Urol 2002; 168: 2510-5
8. Grossfeld GD, Latini DM, Lubeck DP et al. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J Urol 2003; 169: 157-63
9. Moul JW, Douglas TH, McCarthy WF et ai. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol 1996; 155: 1667-73
10. Powell IJ, Banerjee M, Novallo M et al. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Urology 2000; 55: 246-51
11. Newcombe H. PSA doubling times. Lancet Oncol 2000; 1: 14-5
12. Carroll P. Rising PSA after a radical treatment. Eur Urol 2001; 40 (Suppl. 2): 9
13. Partin AW, Hanks GE, Klein EA et al. Prostate-specific antigen as a marker of disease activity in prostate cancer. Oncology (Huntingt) 2002; 16: 1218-24
14. Powell IJ, Heilbrun L, Littrup PL et al. Outcome of African American men screened for prostate cancer: the Detroit Education and Early Detection Study. J Urol 1997; 158: 146-9
15. Powell IJ. Prostate cancer and African-American men. Oncology (Huntingt) 1997; 11: 599-605
16. Powell I. Keynote address: prostate cancer among African-American men - from the bench to the community. J Natl Med Assoc 1998; 90: 5705
17. Powell IJ, Banerjee M, Sakr W et al. Should African-American men be tested for prostate carcinoma at an earlier age than white men? Cancer 1999; 85: 472-7
18. Powell IJ, Dey J, Dudley A et al. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis. Urology 2002; 59: 907-12